ARCHIVES

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

This article is from The Cancer Letter archive.

Vol. 24 No. 47 | December 11, 1998

Download PDF Visit The Full Archive

Related Articles

NCI Clinical Trials Enrollment Drops to 17,500

February 21, 2014

French Cancer Group Vow to Spend More On Cancer Research

January 12, 1996

Samuel Waksal Resigns From ImClone Following Unimpressive ASCO Presentation

May 24, 2002

Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer

June 24, 2005

PhRMA Offers Assistance For Part D “Doughnut Hole”

June 26, 2009

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010